1. Home
  2. HNNA vs VERU Comparison

HNNA vs VERU Comparison

Compare HNNA & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNNA
  • VERU
  • Stock Information
  • Founded
  • HNNA 1989
  • VERU 1971
  • Country
  • HNNA United States
  • VERU United States
  • Employees
  • HNNA N/A
  • VERU N/A
  • Industry
  • HNNA Investment Managers
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNNA Finance
  • VERU Health Care
  • Exchange
  • HNNA Nasdaq
  • VERU Nasdaq
  • Market Cap
  • HNNA 81.2M
  • VERU 88.4M
  • IPO Year
  • HNNA N/A
  • VERU 1990
  • Fundamental
  • Price
  • HNNA $11.10
  • VERU $0.61
  • Analyst Decision
  • HNNA
  • VERU Strong Buy
  • Analyst Count
  • HNNA 0
  • VERU 2
  • Target Price
  • HNNA N/A
  • VERU $4.00
  • AVG Volume (30 Days)
  • HNNA 8.6K
  • VERU 4.2M
  • Earning Date
  • HNNA 08-07-2025
  • VERU 08-07-2025
  • Dividend Yield
  • HNNA 4.96%
  • VERU N/A
  • EPS Growth
  • HNNA 83.55
  • VERU N/A
  • EPS
  • HNNA 1.25
  • VERU N/A
  • Revenue
  • HNNA $35,546,000.00
  • VERU $16,886,419.00
  • Revenue This Year
  • HNNA N/A
  • VERU N/A
  • Revenue Next Year
  • HNNA N/A
  • VERU N/A
  • P/E Ratio
  • HNNA $8.88
  • VERU N/A
  • Revenue Growth
  • HNNA 41.94
  • VERU 134.43
  • 52 Week Low
  • HNNA $6.95
  • VERU $0.45
  • 52 Week High
  • HNNA $13.88
  • VERU $1.42
  • Technical
  • Relative Strength Index (RSI)
  • HNNA 56.42
  • VERU 55.87
  • Support Level
  • HNNA $10.85
  • VERU $0.61
  • Resistance Level
  • HNNA $11.32
  • VERU $0.74
  • Average True Range (ATR)
  • HNNA 0.43
  • VERU 0.06
  • MACD
  • HNNA 0.01
  • VERU 0.01
  • Stochastic Oscillator
  • HNNA 69.92
  • VERU 50.42

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: